College Hill wins new contract with Qiagen

College Hill is to become the corporate and financial PR representative of life science company Qiagen.

Under the terms of its brief with the Nasdaq 100-listed company, College Hill will be aiming to raise Qiagen’s corporate leadership profile on an international basis.

This comes on the back of the successful work done by College Hill representing molecular diagnostics company DxS, which has since been acquired by Qiagen.

College Hill’s managing partner Sue Charles expressed delight at being able to work with the sample and assay technology specialist and hailed its potential to “make a difference” in the healthcare sector.

She added: “It is especially rewarding to be recognised for our work with DxS and to be able to take our programme further under the Qiagen corporate remit.”

Earlier this year, College Hill was named as the European Corporate Consultancy of the Year at the Holmes Report’s annual Agency of the Year awards, recognising the firm’s growth during 2009.